Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: A prospective cohort study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Gunzler, Douglas ^a   Bleyer, Anthony J ^b   Thomas, Robert L ^a   O'Brien, Alicia ^a   Russell, Gregory B ^b   Sattar, Abdus ^a   Iyengar, Sudha K ^a   Thomas, Charles ^a   Sedor, John R ^a   Schelling, Jeffrey R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; CKD; Diabetes; ESRD; Genetics; Progression; Proteinuria

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; CAUSE OF DEATH; CLINICAL EVALUATION; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; EFFECT SIZE; FAMILY HISTORY; FEMALE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; LONGITUDINAL STUDY; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PATIENT MONITORING; PREDICTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SIBLING; AGED; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR;

AGED; ALBUMINURIA; COHORT STUDIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SIBLINGS;

EID: 84879063368     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-124     Document Type: Article

References (37)

1. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Harris MI, Klein R, Welborn TA, Knuiman MW, Diabetes Care 1992 15 815 819 10.2337/diacare.15.7.815 1516497
2. Regression of microalbuminuria in type 1 diabetes. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS, N Engl J Med 2003 348 2285 2293 10.1056/NEJMoa021835 12788992 (Pubitemid 36638102)
3. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients-An indicator of more advanced glomerular lesions. Caramori ML, Fioretto P, Mauer M, Diabetes 2003 52 1036 1040 10.2337/diabetes.52.4.1036 12663477 (Pubitemid 36384275)
4. Temporal trends in the prevalence of diabetic kidney disease in the United States. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J, JAMA 2011 305 2532 2539 10.1001/jama.2011.861 21693741
5. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. Mogensen CE, N Engl J Med 1984 310 356 360 10.1056/NEJM198402093100605 6690964 (Pubitemid 14179541)
6. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
7. Rate of kidney function decline associates with mortality. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, et al. J Am Soc Nephrol 2010 21 1961 1969 10.1681/ASN.2009121210 20947634
8. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. JAMA 2011 305 1545 1552 10.1001/jama.2011.468 21482744
9. Early renal function decline in type 2 diabetes. Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG, Clin J Am Soc Nephrol 2012 7 78 84 10.2215/CJN.07610711 22076874
10. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, De Jong PE, et al. Lancet 2010 375 2073 2081 20483451
11. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, et al. Ann Intern Med 2011 154 12 21 10.7326/0003-4819-154-1-201101040-00003 21200034
12. Genetic susceptibility to end-stage renal disease. Schelling JR, Zarif L, Sehgal A, Iyengar S, Sedor JR, Curr Opin Nephrol Hypertens 1999 8 465 472 10.1097/00041552-199907000-00011 10491742 (Pubitemid 30004171)
13. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, et al. Am J Kidney Dis 2008 51 29 37 10.1053/j.ajkd.2007.10.029 18155530 (Pubitemid 350296526)
14. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, Manzi J, et al. Am J Kidney Dis 2011 58 682 684 10.1053/j.ajkd.2011.05.019 21855190
15. Multiple imputation after 18+ years. Rubin DB, J Am Stat Assoc 1996 91 473 489 10.1080/01621459.1996.10476908
16. Fitzmaurice GM, Laird NM, Ware JH, Applied Longitudinal Analysis New York: John Wiley and Sons 2004
17. The central role of the propensity score in observational studies for causal effects. Rosenbaum PR, Rubin DB, Biometrika 1983 70 41 55 10.1093/biomet/70.1.41
18. Rosenbaum PR, Design of Observational Studies New York: Springer 2010
19. Cox RD, Oakes D, Analysis of Survival Data London: Chapman & Hall 1984
20. Cox's regression model counting process: A large sample study. Andersen PK, Gill RD, Ann Stat 1982 10 1100 1120 10.1214/aos/1176345976
21. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. N Engl J Med 1994 330 877 884 10.1056/NEJM199403313301301 8114857 (Pubitemid 24094966)
22. Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, et al. Clin J Am Soc Nephrol 2009 8 1302 1311
23. Pathophysiology and pathogenesis of diabetic nephropathy. Wolf G, Sharma K, Ziyadeh FN, Seldin and Giebisch's The Kidney: Physiology and Pathophysiology Waltham: Academic, Alpern RJ, Hebert SC, Fourth 2008 2215 2233 18769367
24. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Quinn M, Angelico MC, Warram JH, Krolewski AS, Diabetologia 1996 39 940 945 10.1007/BF00403913 8858216 (Pubitemid 26249113)
25. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, Diabetes 1998 47 821 830 10.2337/diabetes.47.5.821 9588456 (Pubitemid 28201814)
26. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Freedman BI, Tuttle AB, Spray BJ, Am J Kidney Dis 1995 25 710 713 10.1016/0272-6386(95)90546-4 7747724
27. Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia. Iyengar SK, Freedman BI, Sedor JR, Semin Nephrol 2007 27 208 222 10.1016/j.semnephrol.2007.01.004 17418689 (Pubitemid 46550309)
28. Family history of end-stage renal disease does not predict dialytic survival. Freedman BI, Soucie JM, Kenderes B, Krisher J, Garrett LE, Caruana RJ, et al. Am J Kidney Dis 2001 38 547 552 10.1053/ajkd.2001.26851 11532687 (Pubitemid 32803066)
29. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. Forsblom C, Harjutsalo V, Thorn LM, Waden J, Tolonen N, Saraheimo M, et al. J Am Soc Nephrol 2011 22 537 544 10.1681/ASN.2010020194 21335512
30. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, et al. Am J Kidney Dis 2012 59 75 83 10.1053/j.ajkd.2011.09.017 22051245
31. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, et al. Kidney Int 2012 82 589 597 10.1038/ki.2012.189 22622493
32. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Kidney Int 2003 63 225 232 10.1046/j.1523-1755.2003.00712.x 12472787 (Pubitemid 35463925)
33. Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. J Am Soc Nephrol 2012 23 507 515 10.1681/ASN.2011060627 22266663
34. Modeling GFR trajectories in diabetic nephropathy. Lemley KV, Boothroyd DB, Blouch KL, Nelson RG, Jones LI, Olshen RA, et al. Am J Physiol Renal Physiol 2005 289 863 F870 10.1152/ajprenal.00068.2004 15900022 (Pubitemid 41324207)
35. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, et al. J Am Soc Nephrol 2011 22 1931 1937 10.1681/ASN.2010101077 21921144
36. Accuracy of a GFR estimating equation over time in people with a wide range of kidney function. Padala S, Tighiouart H, Inker LA, Contreras G, Beck GJ, Lewis J, et al. Am J Kidney Dis 2012 60 217 224 10.1053/j.ajkd.2012.01.024 22495467
37. Handling missing data in survey research. Brick JM, Kalton G, Stat Methods Med Res 1996 5 215 238 10.1177/096228029600500302 8931194 (Pubitemid 126559353)